Cargando…

Increased insulin sensitivity in individuals with neurofibromatosis type 1

OBJECTS: To compare insulin resistance (IR) and metabolic aspects of patients with neurofibromatosis type 1 (NF1) and individuals without the disease. SUBJECTS AND METHODS: Forty patients with NF1 were matched by sex, age, and body mass index (BMI) to 40 controls from the community. Blood samples we...

Descripción completa

Detalles Bibliográficos
Autores principales:	Martins, Aline Stangherlin, Jansen, Ann Kristine, Rodrigues, Luiz Oswaldo Carneiro, Matos, Camila Maria, Souza, Marcio Leandro Ribeiro, Miranda, Débora Marques, de Rezende, Nilton Alves
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sociedade Brasileira de Endocrinologia e Metabologia 2018
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10118684/ https://www.ncbi.nlm.nih.gov/pubmed/29694637 http://dx.doi.org/10.20945/2359-3997000000007

Ejemplares similares

Lower fasting blood glucose in neurofibromatosis type 1
por: Martins, Aline Stangherlin, et al.
Publicado: (2015)

Non-invasive endothelial function assessment in patients with neurofibromatosis type 1: a cross-sectional study
por: Rodrigues, Luiza O, et al.
Publicado: (2013)

COMT Val(158)Met Polymorphism Is Associated with Verbal Working Memory in Neurofibromatosis Type 1
por: Costa, Danielle de Souza, et al.
Publicado: (2016)

Use of machine learning to predict cognitive performance based on brain metabolism in Neurofibromatosis type 1
por: Schütze, Manuel, et al.
Publicado: (2018)

Neurofibromatosis type 1: evaluation by chest computed tomography
por: Alves Júnior, Sérgio Ferreira, et al.
Publicado: (2021)

Cochlear implant in type 2 neurofibromatosis: an option for better hearing rehabilitation
por: Cruz, Oswaldo Laércio M., et al.
Publicado: (2015)

Total Wrist Arthrodesis: A Preoperative Test to Predict Functional Outcomes
por: Ribeiro, Bruno Adona, et al.
Publicado: (2023)

Plexiform neurofibroma in the ear canal of a patient with Type I Neurofibromatosis
por: Geller, Mauro, et al.
Publicado: (2015)

Neurofibromatosis
por: Gerber, PA, et al.
Publicado: (2009)

Neurofibromatosis
por: Hovinga, Koos E., et al.
Publicado: (2020)

The role of imaging in diagnosing an unusual manifestation of neurofibromatosis type 1: calvarial dysplasia
por: Langer, Felipe Welter, et al.
Publicado: (2018)

Role of NLRP3 inflammasome and oxidative stress in hepatic insulin resistance and the ameliorative effect of phytochemical intervention
por: de Deus, Isabela Jesus, et al.
Publicado: (2023)

Morbidity in the postoperative follow-up of endoscopic anterior skull base surgery
por: Rezende, Gustavo Lara, et al.
Publicado: (2020)

Functional outcomes of proximal row carpectomy: 2-year follow-up
por: Mandarano-Filho, Luiz Garcia, et al.
Publicado: (2015)

Neurofibromatosis : revisión bibliográfica /
por: León Mendoza, Raúl
Publicado: (1987)

Retrolabyrinthine approach for cochlear nerve preservation in neurofibromatosis type 2 and simultaneous cochlear implantation
por: Bento, Ricardo Ferreira, et al.
Publicado: (2013)

Generalised Neurofibromatosis
por: Biggart, J. H.
Publicado: (1941)

Plexiform neurofibromatosis
por: Avhad, Ganesh, et al.
Publicado: (2014)

Segmental neurofibromatosis
por: Galhotra, Virat, et al.
Publicado: (2014)

Segmental neurofibromatosis
por: Sobjanek, Michał, et al.
Publicado: (2014)

Ocular Neurofibromatosis
por: Alkhairy, Saba, et al.
Publicado: (2021)

Segmental Neurofibromatosis
por: Raju, Dimble, et al.
Publicado: (2021)

Activation of the α7 Nicotinic Acetylcholine Receptor Prevents against Microglial-Induced Inflammation and Insulin Resistance in Hypothalamic Neuronal Cells
por: do Amaral, Camila Libardi, et al.
Publicado: (2022)

COVID-19 in people with neurofibromatosis 1, neurofibromatosis 2, or schwannomatosis
por: Banerjee, Jineta, et al.
Publicado: (2023)

Neurofibromatosis 2: hearing restoration options
por: Monteiro, Tatiana Alves, et al.
Publicado: (2015)

Moyamoya syndrome associated with neurofibromatosis type 1 in a pediatric patient
por: Serafini, Natália Battisti, et al.
Publicado: (2017)

Etiopathogenic features of severe epistaxis in histological samples from individuals with or without arterial hypertension
por: Rezende, Gustavo Lara, et al.
Publicado: (2022)

Effects of motor imagery training of Parkinson's disease: a protocol for a randomized clinical trial
por: Nascimento, Isaíra Almeida Pereira da Silva, et al.
Publicado: (2019)

Adiposity markers and insulin resistance in type 1 diabetes patients
por: Marques, Camila Lemos, et al.
Publicado: (2015)

Cranio-orbital-temporal neurofibromatosis: An uncommon subtype of neurofibromatosis type-1
por: Acharya, Nibedita, et al.
Publicado: (2014)

Seizures in children with neurofibromatosis type 1: is neurofibromatosis type 1 enough?
por: Santoro, Claudia, et al.
Publicado: (2018)

Awareness and agreement with neurofibromatosis care guidelines among U.S. neurofibromatosis specialists
por: Merker, Vanessa L., et al.
Publicado: (2022)

Meningioangiomatosis without neurofibromatosis simulating encephalitis in neuroimaging
por: Barbosa-Silva, Everton, et al.
Publicado: (2012)

Neurofibromatosis and childhood leukaemia.
por: Zvulunov, A., et al.
Publicado: (1996)

Neurofibromatosis 1 with pheochromocytoma
por: Hari Kumar, K. V. S., et al.
Publicado: (2011)

Neurofibromatosis type 1
por: Mançano, Alexandre Dias
Publicado: (2022)

Epidemiological profile and clinical characteristics of 491 Brazilian patients with neurofibromatosis type 1
por: Darrigo Junior, Luiz Guilherme, et al.
Publicado: (2022)

Endurance Training Inhibits Insulin Clearance and IDE Expression in Swiss Mice
por: Costa-Júnior, José M., et al.
Publicado: (2015)

Insulin Substrate Receptor (IRS) proteins in normal and malignant hematopoiesis
por: Machado-Neto, João Agostinho, et al.
Publicado: (2018)

Multispectral Imaging Analysis of Skin Lesions in Patients with Neurofibromatosis Type 1
por: Plorina, Emilija V., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_o6l8tbonlljmb6v3o1iv1sotkk